Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. May 23, 2018. Becky Fitzgerald.

Executive Summary

US FDA is working with device firms and outside experts to adopt new tools for appraising companies' manufacturing capability and maturity, leveraging the Capability Maturity Model Integration (CMMI) approach. See what CMMI appraiser and consultant Becky Fitzgerald said about one of FDA's key focus areas for the program here.

"How capable [a company] is to detect that it has a problem and to address it rapidly, and to effectively respond – that's the capability that the FDA is very interested in." – Becky Fitzgerald, principal and cofounder, Two Harbors Consulting

 

Click here for a free trial of Medtech Insight

Topics

UsernamePublicRestriction

Register

MT122710

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel